Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
McKesson
Harvard Business School
AstraZeneca
Express Scripts

Last Updated: June 30, 2022

DIVALPROEX SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Divalproex Sodium patents expire, and when can generic versions of Divalproex Sodium launch?

Divalproex Sodium is a drug marketed by Ajanta Pharma Ltd, Dr Reddys Labs Ltd, Mylan, Teva Pharms Usa, Zydus Pharms Usa Inc, Actavis Labs Fl Inc, Anchen Pharms, Apotex, Aurobindo Pharma Ltd, Celltrion, Invatech, Lupin, Orbion Pharms, Prinston Inc, Sun Pharm Inds, Teva, Unichem Labs Ltd, Upsher Smith Labs, Amneal Pharms, Amta, Cosette, Impax Labs, Lupin Ltd, Reddys, Unichem, and Wockhardt. and is included in thirty-five NDAs.

The generic ingredient in DIVALPROEX SODIUM is divalproex sodium. There are eighteen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.

Drug patent expirations by year for DIVALPROEX SODIUM
Drug Prices for DIVALPROEX SODIUM

See drug prices for DIVALPROEX SODIUM

Drug Sales Revenue Trends for DIVALPROEX SODIUM

See drug sales revenues for DIVALPROEX SODIUM

Recent Clinical Trials for DIVALPROEX SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Syneos HealthPhase 1
NuventraPhase 1
Emalex Biosciences Inc.Phase 1

See all DIVALPROEX SODIUM clinical trials

Paragraph IV (Patent) Challenges for DIVALPROEX SODIUM
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
DEPAKOTE ER Extended-release Tablets divalproex sodium 500 mg 021168 2005-02-08
DEPAKOTE ER Extended-release Tablets divalproex sodium 250 mg 021168 2004-05-03

US Patents and Regulatory Information for DIVALPROEX SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt DIVALPROEX SODIUM divalproex sodium TABLET, EXTENDED RELEASE;ORAL 078705-002 Feb 10, 2009 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Teva DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 076941-001 Jul 29, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Orbion Pharms DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 078853-001 Nov 25, 2008 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Upsher Smith Labs DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 078182-003 Jul 29, 2008 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Colorcon
McKinsey
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.